Understanding how a specific enzyme influences antibody production

Orchestration of the antibody response by PI3K-gamma

NIH-funded research Yale University · NIH-11168253

This study is looking at how a specific enzyme called PI3K-gamma helps our immune system, especially how it affects the way certain immune cells called B cells make antibodies to fight infections, which could lead to better treatments for people with weak immune systems.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University NIH-funded
Lab location1 site (New Haven, United States)
Project IDNIH-11168253 on NIH RePORTER

What this research studies

This research investigates the role of the PI3K-gamma enzyme in the immune system, particularly how it affects the production of antibodies by B cells. By studying mouse models, the researchers aim to uncover the molecular mechanisms that enable B cells to differentiate into antibody-secreting cells, which are crucial for fighting infections. The project will explore how signals from PI3K-gamma influence B cell behavior and antibody responses, potentially leading to new therapeutic strategies for patients with immune deficiencies. The findings could provide insights into improving immune responses in individuals with recurrent infections.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with inborn errors of immunity or recurrent infections due to antibody deficiencies.

Not a fit: Patients with fully functional immune systems or those not experiencing issues with antibody production may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for patients with immune deficiencies, enhancing their ability to produce antibodies and fight infections.

How similar studies have performed: Previous research has shown promising results in understanding the role of PI3K in immune responses, suggesting that this approach could yield valuable insights.

Where this research is happening

New Haven, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.